6TOV | pdb_00006tov

Crystal Structure of Teicoplanin Aglycone


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 0.77 Å
  • R-Value Free: 
    0.114 (Depositor), 0.119 (DCC) 
  • R-Value Work: 
    0.097 (Depositor), 0.101 (DCC) 
  • R-Value Observed: 
    0.097 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 6TOV

This is version 1.1 of the entry. See complete history

Literature

Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase

Bolognino, I.Carrieri, A.Purgatorio, R.Catto, M.Caliandro, R.Carrozzini, B.Belviso, B.D.Majellaro, M.Sotelo, E.Cellamare, S.Altomare, C.D.

(2022) Separations 

Macromolecule Content 

  • Total Structure Weight: 1.6 kDa 
  • Atom Count: 128 
  • Modeled Residue Count: 7 
  • Deposited Residue Count: 7 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:  Sequence   |   3D Structure  
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Teicoplanin Aglycone7synthetic constructMutation(s): 0 

Biologically Interesting Molecules (External Reference) 

1 Unique

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 0.77 Å
  • R-Value Free:  0.114 (Depositor), 0.119 (DCC) 
  • R-Value Work:  0.097 (Depositor), 0.101 (DCC) 
  • R-Value Observed: 0.097 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 35.722α = 90
b = 13.113β = 123.34
c = 21.717γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
Sir2014phasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2020-01-15
    Type: Initial release
  • Version 1.1: 2022-01-19
    Changes: Database references, Derived calculations